Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
The company’s patients can use AI to look at trends going back five years
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Consortium hosts large proteomics dataset for neurodegenerative diseases
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
The skin-based test can be used on children as young as two days old
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Advances could signal changes for clinical laboratories and at-home testing
